Nov 21 (Reuters) - Omeros Corp :
* OMEROS CORPORATION PROVIDES UPDATE ON PROGRESS TOWARD BLA RESUBMISSION
* OMEROS CORP - FDA HAD PREVIOUSLY REQUESTED ADDITIONAL SENSITIVITY ANALYSES FOR SAP
* OMEROS CORP - RECEIVES FDA RESPONSE ON REVISED SAP FOR NARSOPLIMAB BLA
* OMEROS CORP - INDEPENDENT EXPERT STATISTICAL GROUP TO CONDUCT ANALYSES
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments